Genetic determinants of C-reactive protein

Current Atherosclerosis Reports

Volumn 9, Issue 3, 2007, Pages 195-203

  Suk Danik, Jacqueline ^a   Ridker, Paul M ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PHASE RESPONSE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; ENVIRONMENTAL FACTOR; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HERITABILITY; HUMAN; INFLAMMATION; PATHOGENESIS; PHENOTYPE; REVIEW; RISK FACTOR;

ACUTE CORONARY SYNDROME; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CORONARY ARTERY DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; PHENOTYPE; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR NECROSIS FACTOR-ALPHA; VARIATION (GENETICS);

EID: 35449007311     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-007-0019-2     Document Type: Review

References (78)

1. Libby P, Ridker PM: Inflammation and atherothrombosis from population biology and bench research to clinical practice. J Am Coll Cardiol 2006, 48(Suppl 9):A33-46.
2. Libby P: Inflammation in atherosclerosis. Nature 2002, 420:868-874.
3. Ross R: Atherosclerosis - an inflammatory disease. N Engl J Med 1999, 340:115-126.
4. de Maat MP, Trion A: C-reactive protein as a risk factor versus risk marker. Curr Opin Lipidol 2004, 15:651-657.
5. Ridker PM, Hennekens CH, Buring JE, Rifai N: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000, 342:836-843.
6. Pai JK, Pischon T, Ma J, et al.: Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 2004, 351:2599-2610.
7. Danesh J, Wheeler JG, Hirschfield GM, et al.: C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004, 350:1387-1397.
8. Cook NR, Buring JE, Ridker PM: The effect of including c-reactive protein in cardiovascular risk prediction models for women. Ann Intern Med 2006, 145:21-29.
9. Devaraj S, Kumaresan PR, Jialal I: Effect of C-reactive protein on chemokine expression in human aortic endothelial cells. J Mol Cell Cardiol 2004, 36:405-410.
10. Verma S, Li SH, Badiwala MV, et al.: Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation 2002, 105:1890-1896.
11. Pasceri V, Willerson JT, Yeh ET: Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000, 102:2165-2168.
12. Wang CH, Li SH, Weisel RD, et al.: C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation 2003, 107:1783-1790.
13. Wolbink GJ, Brouwer MC, Buysmann S, et al.: CRP-mediated activation of complement in vivo: assessment by measuring circulating complement-C-reactive protein complexes. J Immunol 1996, 157:473-479.
14. Pepys MB, Hirschfield GM: C-reactive protein: a critical update. J Clin Invest 2003, 111:1805-1812.
15. Danenberg HD, Szalai AJ, Swaminathan RV, et al.: Increased thrombosis after arterial injury in human C-reactive protein-transgenic mice. Circulation 2003, 108:512-515.
16. Bisoendial RJ, Kastelein JJ, Levels JH, et al.: Activation of inflammation and coagulation after infusion of C-reactive protein in humans. Circ Res 2005, 96:714-716.
17. Crawford DC, Sanders CL, Qin X, et al.: Genetic variation is associated with C-reactive protein levels in the Third National Health and Nutrition Examination Survey. Circulation 2006, 114:2458-2465.
18. Lange L, Carlson C, Hindorff L, et al.: Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. JAMA 2006, 296:2703-2711.
19. Ridker PM, Cannon CP, Morrow D, et al.: the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Investigators: C-reactive protein levels and outcomes after statin therapy. N Engl J Med 2005, 352:20-28.
20. Pepys MB, Hirschfield GM, Tennent GA, et al.: Targeting C-reactive protein for the treatment of cardiovascular disease. Nature 2006, 440:1217-1221.
21. Boerwinkle E, Ellsworth DL, Hallman DM, Biddinger A: Genetic analysis of atherosclerosis: a research paradigm for the common chronic diseases. Hum Mol Genet 1996, 5 (Spec No):1405-1410.
22. Frohlich J, Dobiasova M, Lear S, Lee KW: The role of risk factors in the development of atherosclerosis. Crit Rev Clin Lab Sci 2001, 38:401-440.
23. Pankow JS, Folsom AR, Cushman M, et al.: Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study. Atherosclerosis 2001, 154:681-689.
24. Vickers MA, Green FR, Terry C, et al.: Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. Cardiovasc Res 2002, 53:1029-1034.
25. Retterstol L, Eikvar L, Berg K: A twin study of C-reactive protein compared to other risk factors for coronary heart disease. Atherosclerosis 2003, 169:279-282.
26. MacGregor AJ, Gallimore JR, Spector TD, Pepys MB: Genetic effects on baseline values of C-reactive protein and serum amyloid a protein: a comparison of monozygotic and dizygotic twins. Clin Chem 2004, 50:130-134.
27. Province MA, Rao DC: General purpose model and a computer program for combined segregation and path analysis (SEGPATH): automatically creating computer programs from symbolic language model specifications. Genet Epidemiol 1995, 12:203-219.
28. Almasy L, Blangero J: Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 1998, 62:1198-1211.
29. Austin MA, Zhang C, Humphries SE, et al.: Heritability of C-reactive protein and association with apolipoprotein E genotypes in Japanese Americans. Ann Hum Genet 2004, 68 (Pt 3):179-188.
30. Kathiresan S, Larson MG, Vasan RS, et al.: Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level. Circulation 2006, 113:1415-1423.
31. Carlson CS, Aldred SF, Lee PK, et al.: Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. Am J Hum Genet 2005, 77:64-77.
32. Miller DT, Zee RY, Suk Danik J, et al.: Association of common CRP gene variants with CRP levels and cardiovascular events. Ann Hum Genet 2005, 69(Pt 6):623-638.
33. Dunning AM, Durocher F, Healey CS, et al.: The extent of linkage disequilibrium in four populations with distinct demographic histories. Am J Hum Genet 2000, 67:1544-1554.
34. Reich DE, Cargill M, Bolk S, et al.: Linkage disequilibrium in the human genome. Nature 2001, 411:199-204.
35. Reich DE, Schaffner SF, Daly MJ, et al.: Human genome sequence variation and the influence of gene history, mutation and recombination. Nat Genet 2002, 32:135-142.
36. Li SP, Liu TY, Goldman ND: cis-acting elements responsible for interleukin-6 inducible C-reactive protein gene expression. J Biol Chem 1990, 265:4136-4142.
37. Russell AI, Cunninghame Graham DS, Shepherd C, et al.: Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet 2004, 13:137-147.
38. Szalai AJ, Wu J, Lange EM, et al.: Single-nucleotide polymorphisms in the C-reactive protein (CRP) gene promoter that affect transcription factor binding, alter transcriptional activity, and associate with differences in baseline serum CRP level. J Mol Med 2005, 83:440-447.
39. Brull DJ, Serrano N, Zito F, et al.: Human CRP gene polymorphism influences CRP levels: implications for the prediction and pathogenesis of coronary heart disease. Arterioscler Thromb Vasc Biol 2003, 23:2063-2069.
40. Zee RY, Ridker PM: Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. Atherosclerosis 2002, 162:217-219.
41. D'Aiuto F, Casas JP, Shah T, et al.: C-reactive protein (+1444C>T) polymorphism influences CRP response following a moderate inflammatory stimulus. Atherosclerosis 2005, 179:413-417.
42. Kovacs A, Green F, Hansson LO, et al.: A novel common single nucleotide polymorphism in the promoter region of the C-reactive protein gene associated with the plasma concentration of C-reactive protein. Atherosclerosis 2005, 178:193-198.
43. Suk HJ, Ridker PM, Cook NR, Zee RY: Relation of polymorphism within the C-reactive protein gene and plasma CRP levels. Atherosclerosis 2005, 178:139-145.
44. Szalai AJ, McCrory MA, Cooper GS, et al.: Association between baseline levels of C-reactive protein (CRP) and a dinucleotide repeat polymorphism in the intron of the CRP gene. Genes Immun 2002, 3:14-19.
45. Szalai AJ, Alarcon GS, Calvo-Alen J, et al.: Systemic lupus erythematosus in a multiethnic US Cohort (LUMINA). XXX: association between C-reactive protein (CRP) gene polymorphisms and vascular events. Rheumatology (Oxford) 2005, 44:864-868.
46. Obisesan TO, Leeuwenburgh C, Phillips T, et al.: C-reactive protein genotypes affect baseline, but not exercise training-induced changes, in C-reactive protein levels. Arterioscler Thromb Vasc Biol 2004, 24:1874-1879.
47. Eklund C, Lehtimaki T, Hurme M: Epistatic effect of C-reactive protein (CRP) single nucleotide polymorphism (SNP) +1059 and interleukin-1B SNP +3954 on CRP concentration in healthy male blood donors. Int J Immunogenet 2005, 32:229-232.
48. Cao H, Hegele RA: Human C-reactive protein (CRP) 1059G/C polymorphism. J Hum Genet 2000, 45:100-101.
49. Chen J, Zhao J, Huang J, et al.: -717A>G polymorphism of human C-reactive protein gene associated with coronary heart disease in ethnic Han Chinese: the Beijing atherosclerosis study. J Mol Med 2005, 83:72-78.
50. Kardys I, de Maat MP, Uitterlinden AG, et al.: C-reactive protein gene haplotypes and risk of coronary heart disease: the Rotterdam Study. Eur Heart J 2006, 27:1331-1337.
51. Cannon CP, Braunwald E, McCabe CH, et al.: Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004, 350:1495-1504.
52. Suk Danik J, Chasman DI, Cannon CP, et al.: Influence of genetic variation in the C-reactive protein gene on the inflammatory response during and after acute coronary ischemia. Ann Hum Genet 2006, 70(Pt 6):705-716.
53. Verschuur M, van der Beek MT, Tak HS, et al.: Interindividual variation in the response by fibrinogen, C-reactive protein and interleukin-6 to yellow fever vaccination. Blood Coagul Fibrinolysis 2004, 15:399-404.
54. Brull DJ, Montgomery HE, Sanders J, et al.: Interleukin-6 gene -174g>c and -572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol 2001, 21:1458-1463.
55. Ferrari SL, Ahn-Luong L, Garnero P, et al.: Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women. J Clin Endocrinol Metab 2003, 88:255-259.
56. Kelberman D, Hawe E, Luong LA, et al.: Effect of Interleukin-6 promoter polymorphisms in survivors of myocardial infarction and matched controls in the North and South of Europe. The HIFMECH Study. Thromb Haemost 2004, 92:1122-1128.
57. Ganter U, Arcone R, Toniatti C, et al.: Dual control of C-reactive protein gene expression by interleukin-1 and interleukin-6. Embo J 1989, 8:3773-3779.
58. Berger P, McConnell JP, Nunn M, et al.: C-reactive protein levels are influenced by common IL-1 gene variations. Cytokine 2002, 17:171-174.
59. Eklund C, Jahan F, Pessi T, et al.: Interleukin 1B gene polymorphism is associated with baseline C-reactive protein levels in healthy individuals. Eur Cytokine Netw 2003, 14:168-171.
60. Libby P, Ridker PM, Maseri A: Inflammation and atherosclerosis. Circulation 2002, 105:1135-1143.
61. Vatay A, Bene L, Kovacs A, et al.: Relationship between the tumor necrosis factor alpha polymorphism and the serum C-reactive protein levels in inflammatory bowel disease. Immunogenetics 2003, 55:247-252.
62. Araujo F, Pereira AC, Mota GF, et al.: The influence of tumor necrosis factor -308 and C-reactive protein G1059C gene variants on serum concentration of C-reactive protein: evidence for an age-dependent association. Clin Chim Acta 2004, 349(1-2):129-134.
63. Papafili A, Hill MR, Brull DJ, et al.: Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response. Arterioscler Thromb Vasc Biol 2002, 22:1631-1636.
64. Cipollone F, Toniato E, Martinotti S, et al.: A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke. JAMA 2004, 291:2221-2228.
65. Kiechl S, Lorenz E, Reindl M, Wiedermann CJ, et al.: Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 2002, 347:185-192.
66. Manttari M, Manninen V, Palosuo T, Ehnholm C: Apolipoprotein E polymorphism and C-reactive protein in dyslipidemic middle-aged men. Atherosclerosis 2001, 156:237-238.
67. Kahri J, Soro-Paavonen A, Ehnholm C, Taskinen MR: ApoE polymorphism is associated with C-reactive protein in low-HDL family members and in normolipidemic subjects. Mediators Inflamm 2006, 2006:12587.
68. Hingorani A, Humphries S: Nature's randomised trials. Lancet 2005, 366:1906-1908.
69. Davey Smith G, Lawlor DA, Harbord R, et al.: Association of C-reactive protein with blood pressure and hypertension: life course confounding and mendelian randomization tests of causality. Arterioscler Thromb Vasc Biol 2005, 25:1051-1056.
70. Timpson NJ, Lawlor DA, Harbord RM, et al.: C-reactive protein and its role in metabolic syndrome: mendelian randomisation study. Lancet 2005, 366:1954-1959.
71. Glynn RJ: Commentary: Genes as instruments for evaluation of markers and causes. Int J Epidemiol 2006, 35:932-934.
72. Casas JP, Shah T, Cooper J, et al.: Insight into the nature of the CRP-coronary event association using Mendelian randomization. Int J Epidemiol 2006, 35:922-931.
73. Wolford JK, Gruber JD, Ossowski VM, et al.: A C-reactive protein promoter polymorphism is associated with type 2 diabetes mellitus in Pima Indians. Mol Genet Metab 2003, 78:136-144.
74. Balistreri CR, Vasto S, Listi F, et al.: Association between +1059G/C CRP polymorphism and acute myocardial infarction in a cohort of patients from Sicily: a pilot study. Ann N Y Acad Sci 2006, 1067:276-281.
75. Morita A, Nakayama T, Soma M: Association study between C-reactive protein genes and ischemic stroke in Japanese subjects. Am J Hypertens 2006, 19:593-600.
76. Ortlepp JR, Graf J, Vesper K, et al.: Relationship of five inflammatory gene polymorphisms with morbidity and mortality in 533 patients admitted to an ICU. Inflammation 2005, 29:1-7.
77. Davey Smith G, Ebrahim S: 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 2003, 32:1-22.
78. Lonn E, Yusuf S, Arnold MJ, et al.: Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 2006, 354:1567-1577.